{"filing":{"accession_number":"0001171843-26-004176","cik":"0001421642","ticker":"MSLE","company_name":"Satellos Bioscience Inc.","form":"6-K","filing_date":"2026-06-17","report_date":null,"primary_document":"f6k_061726.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1421642/000117184326004176/f6k_061726.htm"},"events":[{"id":12409,"run_id":10978,"accession_number":"0001171843-26-004176","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This exhibit is a formal Report of Voting Results from Satellos Bioscience Inc.'s annual shareholder meeting held June 17, 2026. It discloses the outcomes of two matters voted upon: (1) election of nine directors with detailed vote tallies for each nominee, and (2) appointment of PricewaterhouseCoopers LLP as auditor with 98.69% approval. This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 and material to investors assessing board composition and auditor appointment.","company_name":"Satellos Bioscience Inc.","ticker":"MSLE","filing_date":"2026-06-17","form":"6-K","submitted_at":null,"items":[{"id":9249,"accession_number":"0001171843-26-004176","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This exhibit is a formal Report of Voting Results from Satellos Bioscience Inc.'s annual shareholder meeting held June 17, 2026. It discloses the outcomes of two matters voted upon: (1) election of nine directors with detailed vote tallies for each nominee, and (2) appointment of PricewaterhouseCoopers LLP as auditor with 98.69% approval. This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 and material to investors assessing board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:47:43.336162+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9249,"accession_number":"0001171843-26-004176","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This exhibit is a formal Report of Voting Results from Satellos Bioscience Inc.'s annual shareholder meeting held June 17, 2026. It discloses the outcomes of two matters voted upon: (1) election of nine directors with detailed vote tallies for each nominee, and (2) appointment of PricewaterhouseCoopers LLP as auditor with 98.69% approval. This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 and material to investors assessing board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:47:43.336162+00:00","company_name":"Satellos Bioscience Inc.","ticker":"MSLE","filing_date":"2026-06-17"}]}